FDA Issues Warning About Dangers of Teething Products, Wants them off Market

FDA issues warning about dangers of teething products that contain the drug benzocaine. On Wednesday the Food and Drug Administration said that various teething remedies such as gels and creams contain a popular dangerous numbing ingredient.

It warned consumers and asked manufacturers to stop selling their products. Benzocaine can cause rare but deadly side effects among children, especially those 2 years and younger.

The agency now wants teething products off the market as it has been alerting people about the products for a decade. It claims that the products will temporarily relieve a child’s teething pain, but pose a serious risk to infants and children.

Benzocaine can cause a serious condition in which the oxygen level in blood dips dangerously low meaning that it linked to potentially deadly breathing problems. Symptoms include rapid heart rate, headache, sleepiness, lightheadedness, difficulty breathing, skin that is pale and nails that is blue or gray.

The move comes more than four years as in 2006, 2011 and 2014, the FDA issued warnings about the teething remedies. Now, the consumer advocacy group Public Citizen urged the FDA to stop sales of teething products.

Benzocaine products are under the brand names Baby Orajel, Chloraseptic, Orabase, Topex, Anbesol, Cepacol, Hurricaine, and Orajel.

“We urge parents, caregivers, and retailers who sell them to heed our warnings and not use over-the-counter products containing benzocaine for teething pain,” said FDA Commissioner Scott Gottlieb, in a statement.

“The FDA is committed to protecting the American public from products that pose serious safety risks, especially those with no demonstrated benefit,” Gottlieb added.


Marry Saunders

Marry Saunders is a seasoned journalist with nearly a decade under her belt. While studying journalism at the University of Wisconsin, Marry found a passion for finding local stories.  As a contributor to Roswell Gazette, Marry mostly covers human interest stories.

Share this post

Post Comment